Antibody therapeutics have become a cornerstone of modern medicine, used to treat everything from cancer to autoimmune and infectious diseases. Monoclonal antibodies (mAbs) remain the most widely used format, supported by decades of development and well-established manufacturing platforms. Yet even with their success, mAbs still present unsolved purification challenges—from handling host cell process related-impurities, aggregation, and the variability between differing expression systems.
As antibody engineering evolves, new formats like antibody fragments (Fab, scFv) and bispecific antibodies (bsAbs) are expanding what’s possible. These formats enable better tissue penetration, faster clearance, or simultaneous targeting of multiple disease mechanisms. However, their structural differences introduce complexity in downstream processing. Traditional affinity methods like Protein A aren’t always applicable, and new formats often require customized approaches to ensure purity, yield, and scalability.
A flexible, toolbox-based purification strategy is key to unlocking the full potential of mAb and mAb-derived therapeutics.
- Home
- |
- Applications
- |
- Recombinant Proteins
- |
- Antibodies
Antibodies

Our solutions
Fabsorbent™ F1P HF
Fabsorbent™ F1P HF is an appealing, mixed-mode alternative to Protein L for purifying antibody light chain fragments, such as kappa and lambda light chains, Fab and scFv fragments. Using a unique synthetic ligand that demonstrates broad specificity for capture and purification of mAbs and their derivatives, Fabsorbent™ F1P HF has an affinity for both kappa and lambda chains. The synthetic nature allows for robust base-stability, and the PuraBead® 6HF base matrix offers stable flow properties even for large-scale manufacturing. These attributes make it an appealing alternative to expensive Protein A and Protein L ligands as a platform technology.
MAbsorbent® A2P HF
Aminophenylboronate
Aminophenylboronate is an alternative for antibody purification when you need to target glycosylated forms, such as IgG or remove glycosylated impurities. It is especially useful for capturing glycoprotein variants of antibodies or cleaning up unwanted glycated species from complex mixtures, like those expressed in yeast. The resin works by binding cis-diol-containing structures on antibodies and related impurities, allowing for selective capture or polishing. With a stable PuraBead® base, it delivers good flow and is easy to clean, making it a reliable option for refining antibody prep workflows.
HCPure™
PuraBead® IEX
PuraBead® HIC
EtoxiClear®
EtoxiClear® is an advanced endotoxin removal resin designed for high-capacity endotoxin removal across pharmaceutical, biotechnology, and research applications. With superior endotoxin clearance, high protein recovery, and process scalability, it ensures efficient and cost-effective removal of bacterial endotoxin from proteins, buffers, and other biological solutions.